1. Home
  2. POAI vs SBLX Comparison

POAI vs SBLX Comparison

Compare POAI & SBLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POAI
  • SBLX
  • Stock Information
  • Founded
  • POAI 2002
  • SBLX 2017
  • Country
  • POAI United States
  • SBLX United States
  • Employees
  • POAI N/A
  • SBLX N/A
  • Industry
  • POAI Industrial Specialties
  • SBLX Telecommunications Equipment
  • Sector
  • POAI Health Care
  • SBLX Consumer Discretionary
  • Exchange
  • POAI Nasdaq
  • SBLX Nasdaq
  • Market Cap
  • POAI 6.5M
  • SBLX 6.0M
  • IPO Year
  • POAI N/A
  • SBLX N/A
  • Fundamental
  • Price
  • POAI $6.18
  • SBLX $3.47
  • Analyst Decision
  • POAI Hold
  • SBLX
  • Analyst Count
  • POAI 1
  • SBLX 0
  • Target Price
  • POAI N/A
  • SBLX N/A
  • AVG Volume (30 Days)
  • POAI 44.5K
  • SBLX 550.8K
  • Earning Date
  • POAI 11-14-2025
  • SBLX 11-11-2025
  • Dividend Yield
  • POAI N/A
  • SBLX N/A
  • EPS Growth
  • POAI N/A
  • SBLX N/A
  • EPS
  • POAI N/A
  • SBLX N/A
  • Revenue
  • POAI $1,664,696.00
  • SBLX $5,426.00
  • Revenue This Year
  • POAI $486.27
  • SBLX N/A
  • Revenue Next Year
  • POAI $65.50
  • SBLX N/A
  • P/E Ratio
  • POAI N/A
  • SBLX N/A
  • Revenue Growth
  • POAI 71.65
  • SBLX N/A
  • 52 Week Low
  • POAI $4.76
  • SBLX $3.07
  • 52 Week High
  • POAI $45.90
  • SBLX $15.28
  • Technical
  • Relative Strength Index (RSI)
  • POAI 36.97
  • SBLX 30.58
  • Support Level
  • POAI $8.05
  • SBLX $3.53
  • Resistance Level
  • POAI $9.47
  • SBLX $4.99
  • Average True Range (ATR)
  • POAI 0.94
  • SBLX 0.35
  • MACD
  • POAI -0.64
  • SBLX -0.14
  • Stochastic Oscillator
  • POAI 26.61
  • SBLX 18.78

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

About SBLX StableX Technologies Inc. Common Stock

StableX Technologies Inc designs and manufactures compact, sustainable electric vehicles for closed campus mobility, low-speed urban and community transport, local on-demand and last-mile delivery, and government use. It operates as one reportable segment, focusing on the manufacturing and sales of environmentally-conscious, minimal-footprint EVs.

Share on Social Networks: